Davis Polk advised the joint book-running managers in the offering.Solid Biosciences Inc. executed the $143.75 million public offering of common stock. The common stock is listed on…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
